Concerning the employment of viral vectors as vehicle to Id delivery in vivo, preclinical studies were performed in two murine B cell lymphoma models (38C13 and BCL1) to address the vaccine efficacy of Id-encoding adenoviruses (Timmerman et al., 2001). The gene discussed is ID1; the disease is B-cell non-Hodgkin lymphoma.